OTCPK:MEDVF - Post by User
Post by
woolco999on Nov 19, 2021 7:38am
187 Views
Post# 34144536
30-40 cent range in January
30-40 cent range in JanuaryThis has been a brutal ride for so many. A very high percentage have been dumping all year...and tax loss season will continue to keep this company well below its new valuation.
The results speak for themselves. Getting the company turned around and positioned to take advantage of this new medical tech economy was harder than thought. Needed to find the right leadership and mix of business approach to make it work. They have arrived...but only new shareholders are going to reap most of the benefit as the ones that invested in 2020 were taken to the cleaners. Results like below...will drive this to a very significant 9 figure valuation for sure. I for one are going to keep the shares I have not dumped for tax loss...to gamble again that they have it right now.
Q3 Financial Highlights
-
Revenue was $25.3 million in the third quarter of 2021, up 575%, compared to $3.7 million over the prior three-month period ending June 30, 2021.
-
Gross profit was $10.5 million in the third quarter of 2021, up 1,288%, compared to $753,535 over the prior three-month period ending June 30, 2021.
-
Net income was $6.8 million in the third quarter of 2021, compared to a net loss of $8.7 million over the prior three-month period ending June 30, 2021.
-
Cash on balance sheet of $0.9 million and $1.9 million of debt at the end of third quarter 2021